Genetic Technologies is headquartered in Maroochydore, Australia.
Genetic Technologies disclosed revenue of 8M USD for 2024 and 9M USD for 2023.
Genetic Technologies is a life science company.
Genetic Technologies was founded in 1987.
T1 404 Kon-Tiki Business Centre, 55 Plaza Parade,
Maroochydore,
QLD 4558
Australia,
+61 3 0087 6693
www.genetype.com
Genetic Technologies is a diversified molecular diagnostics company that offers cancer predictive testing and assessment tools to help physicians proactively manage patient health. The Company’s products GeneType for Breast Cancer for non-hereditary breast cancer and GeneType for Colorectal Cancer have clinically validated risk assessment tests and are first in class. Genetic Technologies is developing a pipeline of risk assessment products. Genetic Technologies was founded in 1987 and is based in Maroochydore, Australia.
| Year | ≤ '20 | '21 | '22 | '23 | '24 | '25 | T | |
|---|---|---|---|---|---|---|---|---|
| Buy (0.4/yr) | # | - | 1 | 1 | - | - | - | 2 |
| vol | $4M | $4M | ||||||
| Sell (0.0/yr) | # | - | - | - | - | - | - | 0 |
| 2 | ||||||||
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
